Clinical Trial Update: Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the efficacy and safety of Asciminib in patients with newly diagnosed chronic myeloid leukemia in chronic phase is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: RECRUITING